|
| 37163131 | SARS-CoV-2 RBD dimers elicit response comparable to VLPs in mice. | | 2023 |
| 36348617 | Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study. | Journal of Infectious Diseases | 2023 |
| 37844236 | Biphasic decay of intact SHIV genomes following initiation of antiretroviral therapy complicates analysis of interventions targeting the reservoir. | Proc Natl Acad Sci U S A | 2023 |
| 37592872 | SARS-CoV-2 Hybrid Immunity: The Best of Both Worlds. | | 2023 |
| 37734373 | Mpox infection protects against re-challenge in rhesus macaques. | | 2023 |
| 37811993 | Mosaic HIV-1 vaccination induces anti-viral CD8 T cell functionality in the phase 1/2a clinical trial APPROACH. | | 2023 |
| 37802566 | Safety, tolerability, pharmacokinetics, and immunological activity of dual-combinations and triple-combinations of anti-HIV monoclonal antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS administered intravenously to HIV-uninfected adults: a phase 1 ran | | 2023 |
| 37561630 | Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopes. | Cell Rep | 2023 |
| 37872311 | Activation of coagulation and proinflammatory pathways in thrombosis with thrombocytopenia syndrome and following COVID-19 vaccination. | | 2023 |
| 37872011 | Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86. | | 2023 |
| 37961482 | Last in first out: SIV proviruses seeded later in infection are harbored in short-lived CD4<sup>+</sup> T cells. | bioRxiv | 2023 |
| 37095347 | A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines. | | 2023 |
| 37031656 | Isolation of a rhesus calicivirus that can replicate in human cells. | | 2023 |
| 36652339 | Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1. | | 2023 |
| 37467721 | Peripheral blood biomarkers predict viral rebound following antiretroviral therapy discontinuation in SIV-infected, early ART-treated rhesus macaques. | | 2023 |
| 37029141 | Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques. | | 2023 |
| 37082529 | Selective SARS-CoV2 BA.2 escape of antibody Fc/Fc-receptor interactions. | | 2023 |
| 37023746 | Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques. | Cell Rep Med | 2023 |
| 37020354 | Progress in vaccine development for infectious diseases-a Keystone Symposia report. | Ann N Y Acad Sci | 2023 |
| 36809762 | Antiretroviral therapy reveals triphasic decay of intact SIV genomes and persistence of ancestral variants. | Cell Host Microbe | 2023 |
| 36749459 | Altered Cytokine Production in Human Intervillous Blood T Cells in Preeclampsia. | Reprod Sci | 2023 |
| 36630611 | Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters. | | 2023 |
| 36869134 | Publisher Correction: Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice. | NPJ Vaccines | 2023 |
| 36747640 | Waning Immunity Against XBB.1.5 Following Bivalent mRNA Boosters. | | 2023 |
| 37378347 | Attenuated vaccine protection in a low-dose murine challenge model. | | 2023 |
| 36788219 | Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice. | NPJ Vaccines | 2023 |
| 35102312 | Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron. | Nature | 2022 |
| 35530264 | Plasma Proteomics of COVID-19-Associated Cardiovascular Complications: Implications for Pathophysiology and Therapeutics. | JACC Basic Transl Sci | 2022 |
| 35395058 | Ad26.COV2.S prevents upregulation of SARS-CoV-2 induced pathways of inflammation and thrombosis in hamsters and rhesus macaques. | PLoS Pathog | 2022 |
| 36044620 | Covid-19 Vaccines - Immunity, Variants, Boosters. | New England Journal of Medicine | 2022 |
| 35521761 | Reduced SARS-CoV-2 disease outcomes in Syrian hamsters receiving immune sera: Quantitative image analysis in pathologic assessments. | Veterinary Pathology | 2022 |
| 35765315 | Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies. | Open Forum Infect Dis | 2022 |
| 35585080 | Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques. | NPJ Vaccines | 2022 |
| 35452496 | HIV envelope antibodies and TLR7 agonist partially prevent viral rebound in chronically SHIV-infected monkeys. | PLoS Pathogens | 2022 |
| 35512013 | Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates. | PLoS Biol | 2022 |
| 35947380 | Durability of Heterologous and Homologous COVID-19 Vaccine Boosts. | JAMA Netw Open | 2022 |
| 35943359 | CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaques. | Science immunology | 2022 |
| 36000842 | Rapid Loss of CD4 T Cells by Pyroptosis during Acute SIV Infection in Rhesus Macaques. | Journal of Virology | 2022 |
| 35427477 | Vaccine protection against the SARS-CoV-2 Omicron variant in macaques. | Cell | 2022 |
| 35995954 | Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition. | Nature Medicine | 2022 |
| 35933439 | mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant. | Commun Biol | 2022 |
| 35731894 | Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5. | New England Journal of Medicine | 2022 |
| 35551291 | Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial. | Nature Medicine | 2022 |
| 36324798 | Immunogenicity of the BA.5 Bivalent mRNA Vaccine Boosters. | | 2022 |
| 36260835 | Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6. | New England Journal of Medicine | 2022 |
| 36260688 | Genome-wide CRISPR screens identify combinations of candidate latency reversing agents for targeting the latent HIV-1 reservoir. | Sci Transl Med | 2022 |
| 35857825 | Intranasal vaccination with lipid-conjugated immunogens promotes antigen transmucosal uptake to drive mucosal and systemic immunity. | Sci Transl Med | 2022 |
| 35857623 | A bivalent SARS-CoV-2 monoclonal antibody combination does not affect the immunogenicity of a vector-based COVID-19 vaccine in macaques. | Sci Transl Med | 2022 |
| 35981045 | T cell immunity to COVID-19 vaccines. | Science | 2022 |
| 36417525 | Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFN. | Sci Adv | 2022 |